学术探索
学术期刊
学术作者
新闻热点
数据分析
智能评审
Biosimilars: The Debate Continues
被引:21
作者
:
Colbert, Robert A.
论文数:
0
引用数:
0
h-index:
0
机构:
NIAMSD, Pediat Translat Res Branch, NIH, CRC, Bethesda, MD 20892 USA
NIAMSD, Pediat Translat Res Branch, NIH, CRC, Bethesda, MD 20892 USA
Colbert, Robert A.
[
1
]
Cronstein, Bruce N.
论文数:
0
引用数:
0
h-index:
0
机构:
NYU, Sch Med, New York, NY USA
NIAMSD, Pediat Translat Res Branch, NIH, CRC, Bethesda, MD 20892 USA
Cronstein, Bruce N.
[
2
]
机构
:
[1]
NIAMSD, Pediat Translat Res Branch, NIH, CRC, Bethesda, MD 20892 USA
[2]
NYU, Sch Med, New York, NY USA
来源
:
ARTHRITIS AND RHEUMATISM
|
2011年
/ 63卷
/ 10期
关键词
:
D O I
:
10.1002/art.30505
中图分类号
:
R5 [内科学];
学科分类号
:
100201
[内科学]
;
摘要
:
引用
收藏
页码:2848 / 2850
页数:3
相关论文
共 6 条
[1]
[Anonymous], 2011, NAT BIOTECH, V29, P1
[2]
Biosimilars encircle Rituxan, US debates innovator exclusivity
[J].
Carey, Karen
论文数:
0
引用数:
0
h-index:
0
Carey, Karen
.
NATURE BIOTECHNOLOGY,
2011,
29
(03)
:177
-178
[3]
Potential savings from substituting generic drugs for brand-name drugs: Medical Expenditure Panel Survey, 1997-2000
[J].
Haas, JS
论文数:
0
引用数:
0
h-index:
0
机构:
Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02120 USA
Haas, JS
;
Phillips, KA
论文数:
0
引用数:
0
h-index:
0
机构:
Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02120 USA
Phillips, KA
;
Gerstenberger, EP
论文数:
0
引用数:
0
h-index:
0
机构:
Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02120 USA
Gerstenberger, EP
;
Seger, AC
论文数:
0
引用数:
0
h-index:
0
机构:
Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02120 USA
Seger, AC
.
ANNALS OF INTERNAL MEDICINE,
2005,
142
(11)
:891
-897
[4]
Biosimilar epoetins and other "follow-on'' biologics: Update on the European experiences
[J].
Jelkmann, Wolfgang
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Lubeck, Inst Physiol, D-23538 Lubeck, Germany
Univ Lubeck, Inst Physiol, D-23538 Lubeck, Germany
Jelkmann, Wolfgang
.
AMERICAN JOURNAL OF HEMATOLOGY,
2010,
85
(10)
:771
-780
[5]
Hearing shines spotlight on biosimilar controversies
[J].
Mullard, Asher
论文数:
0
引用数:
0
h-index:
0
Mullard, Asher
.
NATURE REVIEWS DRUG DISCOVERY,
2010,
9
(12)
:905
-906
[6]
*US FDA, 2010, FED REG 1005, V75
←
1
→
共 6 条
[1]
[Anonymous], 2011, NAT BIOTECH, V29, P1
[2]
Biosimilars encircle Rituxan, US debates innovator exclusivity
[J].
Carey, Karen
论文数:
0
引用数:
0
h-index:
0
Carey, Karen
.
NATURE BIOTECHNOLOGY,
2011,
29
(03)
:177
-178
[3]
Potential savings from substituting generic drugs for brand-name drugs: Medical Expenditure Panel Survey, 1997-2000
[J].
Haas, JS
论文数:
0
引用数:
0
h-index:
0
机构:
Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02120 USA
Haas, JS
;
Phillips, KA
论文数:
0
引用数:
0
h-index:
0
机构:
Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02120 USA
Phillips, KA
;
Gerstenberger, EP
论文数:
0
引用数:
0
h-index:
0
机构:
Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02120 USA
Gerstenberger, EP
;
Seger, AC
论文数:
0
引用数:
0
h-index:
0
机构:
Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02120 USA
Seger, AC
.
ANNALS OF INTERNAL MEDICINE,
2005,
142
(11)
:891
-897
[4]
Biosimilar epoetins and other "follow-on'' biologics: Update on the European experiences
[J].
Jelkmann, Wolfgang
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Lubeck, Inst Physiol, D-23538 Lubeck, Germany
Univ Lubeck, Inst Physiol, D-23538 Lubeck, Germany
Jelkmann, Wolfgang
.
AMERICAN JOURNAL OF HEMATOLOGY,
2010,
85
(10)
:771
-780
[5]
Hearing shines spotlight on biosimilar controversies
[J].
Mullard, Asher
论文数:
0
引用数:
0
h-index:
0
Mullard, Asher
.
NATURE REVIEWS DRUG DISCOVERY,
2010,
9
(12)
:905
-906
[6]
*US FDA, 2010, FED REG 1005, V75
←
1
→